Interesting! Has fast track orphan drug status and lots of money with tie-in to J&J. I think XKEM's market in Nigeria and Africa is their stronghold for now and will be very lucrative on a volume basis. I think XKEM is part of a new revolution in the pharma industry which will see big pharma companies battle companies like XKEM that develop new drugs from natural sources as opposed to expensive laboratory developed chemicals.
“A fool and his money are soon parted.” ~Thomas Tusser
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.